Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)

Overview

This article describes the technical aspects of performing Luciferase Immunoprecipitation Systems (LIPS), focusing on the expression of chimeric genes in mammalian cells. The method involves using crude extracts for immunoprecipitation assays to quantify antibodies.

Key Study Components

Area of Science

• Neuroscience
• Immunology
• Biotechnology

Background

• LIPS is a technique used to measure antibody titers.
• It can aid in diagnosing diseases and infections.
• The method utilizes Renilla luciferase fusions for antigen expression.
• Crude extracts are used without purification, streamlining the process.

Purpose of Study

• To demonstrate the procedure for LIPS.
• To provide a method for quantifying antibodies in various applications.
• To facilitate the generation of antibody profiles for disease monitoring.

Methods Used

• Transfection of COS-1 cells with plasmids encoding luciferase fusions.
• Preparation of crude extracts from harvested cells.
• Immunoprecipitation using protein A/G beads.
• Measurement of luminescence to quantify antibody binding.

Main Results

• The LIPS assay successfully quantifies antibodies from crude extracts.
• Antibody-antigen interactions are effectively captured using protein A/G beads.
• Results demonstrate the utility of LIPS in clinical and research settings.
• The method is efficient and reproducible for antibody profiling.

Conclusions

• LIPS is a valuable tool for measuring antibody levels.
• The technique can be applied to various research and diagnostic applications.
• Future studies may expand its use in different disease contexts.

Frequently Asked Questions